They have approval to market end of FY2023 which was accurate based on FDA Clearance. There was a secondary was that they expect distribution announcements by end of CY2023.
FDA Clearance Announcement:
July Quarterly:
Full Year Results:
August Quarterly:
Recent AGM:
Its simply a typo.
The re-rate journey, page-250
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.002(4.44%) |
Mkt cap ! $20.69M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.3¢ | $14.21K | 330.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60000 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 135934 | 1 |
View Market Depth
| Last trade - 15.31pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.3¢ |
Change
-0.002 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 4.3¢ | 4.3¢ | 4.3¢ | 68550 | ||
| Last updated 15.36pm 21/05/2024 ? | |||||
| LDX (ASX) Chart |